[EN] COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES [FR] COMPOSÉS POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
摘要:
Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.
The tridentate phosphine ligand 1,3,5-tris[(E)-(4-phospholano-2,6-diethyl)styryl]benzene (1) reacts with [AuCl(tht)] (tht = tetrahydrothiophene) independent of the stoichiometry employed with selective formation of a two-dimensional coordinationpolymer (ratio 1 : 1) with the gold(I) cations in a trigonal-planar [3 + 1] coordination geometry. Each of the three coordinating phosphine units originates
[EN] AZETIDINYL COMPOUNDS COMPRISING A CARBOXYLIC ACID GROUP FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES<br/>[FR] COMPOSÉS AZÉTIDINYLES COMPRENANT UN GROUPE ACIDE CARBOXYLIQUE POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
申请人:CELGENE CORP
公开号:WO2022266162A1
公开(公告)日:2022-12-22
Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.